GeneDx Holdings Corp. (WGS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2019: -$30.41M2020: -$241.99M2021: -$446.15M2022: -$667.65M2023: -$180.60M2024: -$23.21M2025: -$13.08M-$13.08M
2019Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$13.08M+43.7%
2024-$23.21M+87.1%
2023-$180.60M+73.0%
2022-$667.65M-49.6%
2021-$446.15M-84.4%
2020-$241.99M-695.7%
2019-$30.41M